From evidence to market: Alfred Spinks's 1953 survey of new fields for pharmacological research, and the origins of ICI's cardiovascular programme

Medicine, the Market and the Mass Media: Producing Health in the Twentieth Century

Volumn , Issue , 2005, Pages 146-171

  Quirke, Viviane ^a  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55049133944     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203694541     Document Type: Chapter

References (6)

1. A.M. Barrett, 'Design of β-blocking drugs', in E. Ariëns (ed.), Drug Design, vol. 3, New York: Academic Press, 1972, pp. 205-28.
2. A.W. Johnson, F.L. Rose and C.W. Suckling, 'Alfred Spinks, 1917-1982', Biographical Memoirs of Fellows of the Royal Society 30, 1984, pp. 567-94.
3. C. Kennedy, ICI: the Company That Changed Our Lives, London: Hutchinson, 1986.
4. W.J. Reader, Imperial Chemical Industries: a History, vol. 2, London: Oxford University Press, 1979.
5. R.G. Shanks, 'The discovery of beta adrenoceptor blocking drugs', in M.J. Parnham and J. Bruinvels (eds), Discoveries in Pharmacology, vol. 2, Amsterdam: Elsevier, 1984, pp. 38-72.
6. R. Vos, Drugs Looking for Diseases: Innovative Drug Research and the Development of the Beta-blockers and the Calcium Antagonists, Dordrecht: Kluwer, 1991.